COMBINATORIAL TARGETED THERAPY OF MAB AND NINTEDANIB ENHANCES CANCER CELL LETHALITY

Ph.D

Saved in:

Bibliographic Details
Main Author:	TEO WAN CHING JOCELYN
Other Authors:	INTEGRATIVE SCIENCES & ENGINEERING PROG
Format:	Theses and Dissertations
Language:	English
Published:	2021
Subjects:	monoclonal antibodies, combinatorial therapy, angiokinase inhibitor, EMT, medical oncology, glycomics
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/190512
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore
Language:	English

id	sg-nus-scholar.10635-190512
record_format	dspace
spelling	sg-nus-scholar.10635-1905122021-05-02T13:11:53Z COMBINATORIAL TARGETED THERAPY OF MAB AND NINTEDANIB ENHANCES CANCER CELL LETHALITY TEO WAN CHING JOCELYN INTEGRATIVE SCIENCES & ENGINEERING PROG Boon Hwa, Andre Choo monoclonal antibodies, combinatorial therapy, angiokinase inhibitor, EMT, medical oncology, glycomics Ph.D DOCTOR OF PHILOSOPHY (NGS) 2021-04-30T18:01:07Z 2021-04-30T18:01:07Z 2019-01-23 Thesis TEO WAN CHING JOCELYN (2019-01-23). COMBINATORIAL TARGETED THERAPY OF MAB AND NINTEDANIB ENHANCES CANCER CELL LETHALITY. ScholarBank@NUS Repository. https://scholarbank.nus.edu.sg/handle/10635/190512 en
institution	National University of Singapore
building	NUS Library
continent	Asia
country	Singapore Singapore
content_provider	NUS Library
collection	ScholarBank@NUS
language	English
topic	monoclonal antibodies, combinatorial therapy, angiokinase inhibitor, EMT, medical oncology, glycomics
spellingShingle	monoclonal antibodies, combinatorial therapy, angiokinase inhibitor, EMT, medical oncology, glycomics TEO WAN CHING JOCELYN COMBINATORIAL TARGETED THERAPY OF MAB AND NINTEDANIB ENHANCES CANCER CELL LETHALITY
description	Ph.D
author2	INTEGRATIVE SCIENCES & ENGINEERING PROG
author_facet	INTEGRATIVE SCIENCES & ENGINEERING PROG TEO WAN CHING JOCELYN
format	Theses and Dissertations
author	TEO WAN CHING JOCELYN
author_sort	TEO WAN CHING JOCELYN
title	COMBINATORIAL TARGETED THERAPY OF MAB AND NINTEDANIB ENHANCES CANCER CELL LETHALITY
title_short	COMBINATORIAL TARGETED THERAPY OF MAB AND NINTEDANIB ENHANCES CANCER CELL LETHALITY
title_full	COMBINATORIAL TARGETED THERAPY OF MAB AND NINTEDANIB ENHANCES CANCER CELL LETHALITY
title_fullStr	COMBINATORIAL TARGETED THERAPY OF MAB AND NINTEDANIB ENHANCES CANCER CELL LETHALITY
title_full_unstemmed	COMBINATORIAL TARGETED THERAPY OF MAB AND NINTEDANIB ENHANCES CANCER CELL LETHALITY
title_sort	combinatorial targeted therapy of mab and nintedanib enhances cancer cell lethality
publishDate	2021
url	https://scholarbank.nus.edu.sg/handle/10635/190512
_version_	1698713626170359808

COMBINATORIAL TARGETED THERAPY OF MAB AND NINTEDANIB ENHANCES CANCER CELL LETHALITY

Similar Items